Incentivizing Capacity Investments for Global Health Products

53 Pages Posted: 22 Jun 2020 Last revised: 1 Feb 2021

See all articles by Burak Kazaz

Burak Kazaz

Syracuse University - Whitman School of Management

Scott Webster

Arizona State University

Prashant Yadav

INSEAD; Harvard Medical School

Date Written: April 23, 2020


We study mechanisms that encourage manufacturers of global health products to build production capacity. This is particularly important for health products manufactured for low- and middle-income country (LMIC) markets where willingness to pay is lower and demand risks are greater. As a result, manufacturers can be hesitant to invest to serve these markets at an affordable price for those in need.

Development finance institutions and philanthropies are beginning to utilize new instruments to incentivize production/distribution for LMIC markets. The goal of this paper is to understand the effectiveness of such mechanisms in different settings, and to translate our understanding into a framework to guide social investors.

We examine four instruments – sales subsidy, capacity subsidy, low interest (concessional) loan, and volume guarantee – and obtain the following results: A capacity subsidy is less costly than a sales subsidy, but a sales subsidy is viable at lower levels of capacity and is less susceptible to moral hazard. A concessional loan has a payment structure similar to a capacity subsidy but has an important difference: while manufacturer savings and social investor cost are the same under a capacity subsidy, these values are linked to the costs of capital under a concessional loan and can be substantially different. A volume guarantee targets manufacturer’s risk rather than relying on the manufacturer’s private cost information. It becomes especially attractive in settings where the social investor has a more favorable and accurate view of the market and where uncertainty around the manufacturer’s cost structure is high.

Keywords: global health, social investor, private investment

Suggested Citation

Kazaz, Burak and Webster, Scott and Yadav, Prashant, Incentivizing Capacity Investments for Global Health Products (April 23, 2020). Available at SSRN: or

Burak Kazaz

Syracuse University - Whitman School of Management ( email )

721 University Avenue
Syracuse, NY 13244
United States
(315) 443-7381 (Phone)
(315) 442-1461 (Fax)

HOME PAGE: http://

Scott Webster (Contact Author)

Arizona State University ( email )

W.P. Carey School of Business
350 E. Lemon St
Tempe, AZ 85282
United States

Prashant Yadav

INSEAD ( email )

Boulevard de Constance
77 305 Fontainebleau Cedex

Harvard Medical School ( email )

25 Shattuck St
Boston, MA 02115
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
PlumX Metrics